$796.00 – $1,592.00
Mergers and Acquisitions in the IVD Market
Mergers and Acquisitions (M&A) activity in the in vitro diagnostics (IVD) market was brisk in 2016. Kalorama’s report records 250 acquisitions in the industry from 2013-2016. Becton Dickinson (BD), Danaher, Roche, and Thermo Fisher Scientific were among the companies active in M&A during this period.
Chapter 1: Executive Summary
The Market Landscape
Mergers and Acquisitions
Methodology
Chapter 2: IVD Mergers and Acquisitions
Introduction
Select Top Tier IVD Company Activities in 2015 and 2016
The Proposed Acquisition of Alere by Abbott
Roche Remains Active in M&A
Siemens’ Plan to Divest Its Healthcare Business, Siemens Healthineers
Danaher’s Acquisition of Molecular Diagnostics Leader Cepheid
Abbott Acquires St. Jude Medical, Adds Patient Monitoring and Neurostimulation
Strength
Thermo Fisher Scientific Acquires Affymetrix
Beckman Coulter Acquires Siemens Healthcare Diagnostics’ Clinical Microbiology
Business
Becton Dickinson (BD) Prepares Its Entrance into Sequencing with Cellular
Research Acquisition
Other 2015-2016 Acquisitions of Note
Luminex’s Acquisition of Nanosphere
Quest and DiaSorin to Focus on Key Markets Following Acquisition Deal
IBM Healthcare/Watson Continues Expansion
Select 2013-2014 Acquisitions of Note
Abbott Diagnostics
Mergers and Acquisitions in the IVD Market
ii January 2017 © Kalorama Information
Johnson and Johnson (J&J)
Thermo Fisher
Becton Dickinson
bioMérieux
Bio-Rad Laboratories
Arkray
QIAGEN
Radiometer
Trinity Biotech
Grifols International
List of Exhibits
Chapter 2: IVD Mergers and Acquisitions
Table 2-1: Selected Acquisitions of Diagnostic Companies, 2015-2016
Table 2-2: Selected Acquisitions of Diagnostic Companies, 2013-2014
